National Institute Of Arthritis And Musculoskeletal And Skin Diseases (niams)
Clinical trials sponsored by National Institute Of Arthritis And Musculoskeletal And Skin Diseases (niams), explained in plain language.
-
Promising skin drug trial for rare muscle disease pulled before start
Disease control TerminatedThis study aimed to test deucravacitinib, a pill already approved for psoriasis, in adults with dermatomyositis or juvenile dermatomyositis that did not respond to standard treatments. The goal was to see if the drug could improve muscle and skin symptoms. However, the study was …
Phase: PHASE2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Massive data dive reveals hidden risks in common bone surgeries
Knowledge-focused OngoingThis study looks at medical records from over 500,000 Medicare patients who had major orthopedic surgeries like hip or knee replacements. The goal is to find out how often complications happen and how care can be improved. No new treatments are tested—researchers are just analyzi…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated May 17, 2026 01:49 UTC